Alumis Inc. ALMS Business Segments — Nonoperating Income Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Alumis Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Alumis Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alumis Inc.'s business segments — nonoperating income expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alumis Inc.'s business segments — nonoperating income expense?
- Alumis Inc. (ALMS) reported business segments — nonoperating income expense of $5.36M in Q1 2026.
- How has Alumis Inc.'s business segments — nonoperating income expense changed year-over-year?
- Alumis Inc.'s business segments — nonoperating income expense increased by 108.8% year-over-year, from $2.57M to $5.36M.
- What is the long-term trend for Alumis Inc.'s business segments — nonoperating income expense?
- Over 2 years (2023 to 2025), Alumis Inc.'s business segments — nonoperating income expense has grown at a 696.7% compound annual growth rate (CAGR), from $3.18M to $201.92M.
- What does business segments — nonoperating income expense mean?
- This metric represents financial gains or losses generated from activities outside of the company's core biopharmaceutical operations, such as interest income, investment returns, or foreign exchange fluctuations. It provides insight into the company's treasury management and the impact of non-core financial activities on the overall bottom line. Monitoring this helps investors distinguish between operational performance and peripheral financial results.